Invitrogen™ Lipofectamine™ CRISPRMAX™ Cas9 Transfection Reagent
First optimized lipid nanoparticle transfection reagent for CRISPR-Cas9 protein delivery
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
CRISPR-Cas9 is a revolutionary.
Transfection
Lipofectamine™ CRISPRMAX™ Cas9 is an exceptional product, offering efficient and precise gene editing capabilities that empower researchers to unlock groundbreaking discoveries in the field of genetic engineering.
Review Date: 23 Jan 2024 | Thermo Fisher Scientific
Lipofectamine CRISPRMAX Cas9 Transfection Reagent is the first optimized lipid nanoparticle transfection reagent for CRISPR-Cas9 protein delivery. It is a high-throughput-friendly, cost-effective alternative to electroporation. Working together with our TrueCut Cas9 Protein v2 and TrueGuide Synthetic gRNA, it provides: • Demonstrated cleavage efficiency—tested in over 20 cell types including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and several others • Low cell toxicity—less cells needed to initiate your experiment • High throughput friendly—an ideal delivery solution for 96-well format • Cost savings—whether cost-per-reaction or initial investment
